Integrated BioPharma (OTCMKTS:INBP) Trading Up 1.6% – Time to Buy?

Integrated BioPharma Inc. (OTCMKTS:INBP)’s stock price shot up 1.6% on Monday . The company traded as high as $0.3220 and last traded at $0.32. 24,725 shares were traded during mid-day trading, an increase of 32% from the average session volume of 18,668 shares. The stock had previously closed at $0.3150.

Integrated BioPharma Stock Performance

The company has a current ratio of 4.42, a quick ratio of 2.21 and a debt-to-equity ratio of 0.01. The stock has a market cap of $9.76 million, a PE ratio of 15.76 and a beta of 0.95. The business’s 50-day moving average price is $0.30 and its 200-day moving average price is $0.30.

Integrated BioPharma (OTCMKTS:INBP) last posted its earnings results on Tuesday, September 23rd. The company reported ($0.01) EPS for the quarter. Integrated BioPharma had a net margin of 1.49% and a return on equity of 4.04%. The firm had revenue of $14.18 million for the quarter.

About Integrated BioPharma

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.